genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2019
Fentanyl
Drug Discovery
Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate Aimed at Fentanyl
A-Lists
Top 25 Abused Prescription Drugs of 2014
Resources
High Sensitivity Analysis of Fentanyl
Cancer
EC Regulator Rubber-Stamps Archimedes’ Intranasal Fentanyl Spray for Cancer Pain
News
Orexo Gets $10M Up Front under Respiratory Disease Alliance with Ortho-McNeil and Janssen
Cancer
Nycomed’s Intranasal Fentanyl Drug Gains European Approval for Breakthrough Cancer Pain
Scroll Up
Scroll Up
